Picture of Nephros logo

NEPH — Nephros News Story

0.000.00%
us flag iconLast trade - 00:00
IndustrialsAdventurousMicro CapNeutral

Nephros Inc reports results for the quarter ended in September 30 - Earnings Summary

* Nephros Inc  NEPH.OQ  reported quarterly adjusted earnings
of 2
cents​​ per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of -2 cents.  The mean expectation of two analysts for the
quarter was for a loss of 2 cents per share. 
    * Revenue fell 6% to $3.52 million from a year ago; analysts
expected $3.50 million. 
    * Nephros Inc's reported EPS for the quarter was 2 cents​.
    * The company reported quarterly net income of $183
thousand.
    * Nephros Inc shares had fallen by 11.1% this quarter and
lost 56.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 100%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the environmental
services & equipment peer group is also "buy"

Wall Street's median 12-month price target for Nephros Inc is
$4.75 
This summary was machine generated from LSEG data November 8 at
05:13 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.02          0.02           Beat
 Jun. 30 2024      -0.01          -0.03          Missed
 Mar. 31 2024      -0.04          -0.02          Beat
 Dec. 31 2023      -0.02          -0.06          Missed

Recent news on Nephros

See all news